Ashwini Zolekar, BPharm, MS
Ashwini Zolekar is the 2019-2021 UIC-AbbVie Health Economics and Outcomes Research Fellow (HEOR). She received her Master of Biotechnology (Pharmaceutical track) degree in 2013 from the University of Pennsylvania and Bachelor of Pharmacy degree from University of Mumbai. Prior to joining UIC, she worked as a research specialist in the Cancer and Regenerative Medicine Department of the University of North Texas Health Science Center where she worked on genomics and survival outcomes of cancer patients. Prior to that she worked as an associate researcher in the Institute of Genomics and Multiscale Biology of Mount Sinai Medica Centre. Her current research interests include comparative effective research, cancer genomics and outcomes and pharmacoepidemiology.
Danny Quach, PharmD
Danny Quach is a 2019-2021 UIC-AbbVie Fellow in Health Economics and Outcomes Research (HEOR). Dr. Quach received his Doctor of Pharmacy degree at the University of Washington School of Pharmacy in Seattle, WA. His interest in HEOR developed during pharmacy school where he took HEOR courses at and did research with the faculty there. Before joining the UIC Pharmacy Systems, Outcomes, and Policy department, Dr. Quach was an HEOR analyst for Maple Health Group, Global Strategy Consulting Firm. Dr. Quach’s research interests include comparative effectiveness, economic modeling, budget impact modeling, outcomes-based pricing and policies, and prediction modeling.
Claire Huang, MPH
Hsiao- Ching (Claire) Huang is the 2020 – 2022 UIC/AbbVie Fellow in Global Epidemiology team under Pharmacovigilance and Patients Safety (PPS). Claire obtained her Master of Public Health (MPH) degree concentrating in biostatistics from University of Illinois at Chicago in 2017. After graduating from her MPH, she worked as a statistical analyst at Sutter Health in San Francisco Bay Area where she developed her passion in pharmacoepidemiology. Her experience at Sutter Health allowed her to gain insights using Electronic Health Records (EHR) and combined her biostatistics background with various pharmacoepidemiology research. Her current research interest includes pharmacoepidemiology, drug safety, and advanced epidemiology methods.
Kent Hanson, PharmD
Kent Hanson is the 2020-2022 UIC-Pfizer fellow in Health Economics and Outcomes Research (HEOR). Kent received his Doctor of Pharmacy degree from the University of Illinois Chicago College of Pharmacy in 2020. He became interested in HEOR after working with faculty in the Pharmacy Systems Outcomes and Policy department to research performance-based risk-sharing agreements and generate reports for the Institute for Clinical and Economic Review. Kent’s research interests include pharmacoepidemiology, comparative effectiveness research, pharmacoeconomic evaluations, and patient-reported outcomes.
Huiwen Deng, MPH, PharmD
Huiwen Deng is the 2020-2022 UIC-AbbVie Fellow in the Health Economics and Outcomes Research (HEOR). She earned her Master of Public Health and Doctor of Pharmacy degrees from the University of Iowa in 2018 and 2019. Dr. Deng developed her passion through academic research evaluating health policies’ impacts on drug and medical device coverages. Dr. Deng’s current research interests include drug effectiveness, medication safety, and cost-effectiveness assessments. Dr. Deng’s disease states of interest include oncology, immunology, cardiovascular diseases, and infectious diseases.
Zaid Yousif, PharmD
Zaid Yousif is the 2021-2022 UIC-Takeda Fellow in Health Economics and Outcomes Research (HEOR). He received his Doctor of Pharmacy degree in 2018 from the University of San Diego, California Skaggs School of Pharmacy. His interest in HEOR developed after completing graduate courses in biostatistics, epidemiology, and clinical decision analysis. Dr. Yousif’s research interests include health outcomes, disease phenotyping, and cost-effectiveness analysis. Dr. Yousif’s disease states of interest include acute kidney disease, Crohn’s disease, and epilepsy.
Kandavadivu Umashankar, MS, PharmD
Kandavadivu Umashankar is the 2021-2022 UIC Takeda Fellow in Health Economics and Outcomes Research(HEOR). Kanda earned an MS in Pharmacoeconomics and Policy from MCPHS University, Boston, and a Doctor of Pharmacy from Sri Ramachandra Institute of Higher Education and Research, India. Kanda developed a passion for the field during her graduate school while working on outcomes research projects. She enjoys employing rigorous scientific methods to provide HEOR solutions to policymakers, pharma companies, patients, and payers. Her research interests include real-world evidence synthesis, economic modeling, and comparative effectiveness research for drugs and medical technologies.
Jon Nazari, PharmD
Jon Nazari is the 2021-2023 UIC/Pfizer Fellow in Health Economics and Outcomes Research (HEOR). Jon received his Doctor of Pharmacy (PharmD) degree from the University of Illinois at Chicago College of Pharmacy in 2019. While a PharmD student, Jon gained exposure to the UIC Department of Pharmacy Systems, Outcomes, and Policy while participating as an interviewer in the US valuation study for the EQ-5D-5L. This served as his introduction to the field of HEOR. His current research interests include patient-centered outcomes research, quality of life assessment, health economic evaluations, and global market access.
Monika Mandava, PharmD
Monika Rao Mandava is the 2021 – 2023 UIC–AbbVie fellow in Health Economics and Outcomes Research (HEOR). Monika received her Doctor of Pharmacy degree in 2019 from Jawaharlal Nehru Technological University in Hyderabad, India. Her interest in HEOR developed while networking with HEOR scientists and being involved in several health outcomes research and real-world evidence projects. Her current research interests include real-world evidence, access to healthcare, and racial disparities.
Mrinmayee Joshi, BPharm
Mrinmayee Joshi is the 2021-2023 UIC-AbbVie Fellow in Health Economics and Outcomes Research (HEOR). Mrinmayee received her Bachelor of Pharmacy degree from the University of Mumbai in 2019. She developed an interest in HEOR while working on academic research on identifying barriers to Human Papillomavirus vaccine uptake; and impact of government-mandated price ceiling on the cost and utilization of coronary stents in India. Her passion for research was bolstered after attending various international conferences to present her work, and networking with professionals in HEOR. She has worked on several projects evaluating the cost-effectiveness of novel pharmaceuticals in various disease states. Her current research interests include comparative effectiveness, economic evaluation and pharmacoepidemiology, especially in the areas of oncology and immunology.
Sun Choi, PharmD
Sun Choi is the 2021-2023 UIC-Takeda fellow in Health Economics and Outcomes Research (HEOR). Sun received her Doctor of Pharmacy degree from UIC in 2021. Her interest in HEOR developed through academic research in cost-effectiveness studies of drug interventions, investigation of health policy implementation, and retrospective assessment of medication adherence. Prior to her fellowship, she worked as an intern at Milliman and BlueCross BlueShield Association. Her current research interests include pharmacoeconomic evaluation and real-world evidence of gene therapies and CAR-T therapies.